TNFSF10 and exocrine pancreatic carcinoma: Most importantly, the administration of TRAIL to tumor-bearing mice led to increased metastasis in an orthotopic xenograft pancreatic carcinoma model employing severe combined immunodeficient(SCID) mice [32].